BIOMAT Database Logo BIOMAT Database Logo

Risk factors for maternal HTLV-I infection in French Guiana: high HTLV-I prevalence in the Noir Marron population. 1995

P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
Unité d'Epidémiologie des Virus Oncogènes, Institut Pasteur, Paris, France.

The aim of this study was to compare rates of human T-cell lymphotropic virus type I (HTLV-I) seroprevalence in pregnant women belonging to different ethnic groups in French Guiana and to determine the risk factors associated with HTLV-I seropositivity. All 1,873 deliveries between 1 July 1991 and 30 June 1993 in the only gynecologic and obstetric unit at Saint Laurent du Maroni were enrolled. Serologic status could be established for 1,727 women, with 75 (4.3%) being HTLV-I seropositive. The HTLV-I seroprevalence rate differed significantly between ethnic groups: 5.7% for Noir-Marron (70/1,302), 6.3% for Haitian (3/50), and 0% for Creole (126), Amerindians (166), and Hmong (64). In Noir-Marron pregnant women, HTLV-I seropositivity was associated with a maternal age of > 35 years [odds ratio (OR), 3.3; 95% confidence interval (CI), 1.4-7.6], prior miscarriage (OR, 1.7; CI, 1-2.8), prior cesarean section (OR, 2.1; CI, 1.1-4.0), a parity > 4 (OR, 4.0; CI, 1.8-8.8), a gravidity > 6 (OR, 4.2; CI, 2.0-7.2), and a negative Rhesus factor (OR, 2.2; CI, 1.1-4.5). Two separate stepwise logistic regressions were done because gravidity and parity were highly correlated. HTLV-I seropositivity remained associated with a gravidity > 6 (OR, 3.9; CI, 2.1-7.4) and a negative Rhesus factor (OR, 2.6; CI, 1.2-5.3) for the first model and with a parity > 4 (OR, 4.1; CI, 1.9-9.0) and a negative Rhesus factor (OR, 2.5; CI, 1.2-5.1) for the second model.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005616 French Guiana A French overseas department on the northeast coast of South America. Its capital is Cayenne. It was first settled by the French in 1604. Early development was hindered because of the presence of a penal colony. The name of the country and the capital are variants of Guyana, possibly from the native Indian Guarani guai (born) + ana (kin), implying a united and interrelated race of people. (From Webster's New Geographical Dictionary, 1988, p418 & Room, Brewer's Dictionary of Names, 1992, p195)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV

Related Publications

P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
[Neuromyelopathy in the population of Noir-marron of Saint-Laurent du Maroni in French Guiana].
January 1997, Bulletin de la Societe de pathologie exotique (1990),
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
Frequency and characterization of RHD and RHCE variants in the Noir Marron population from French Guiana.
December 2022, Transfusion,
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
The imprint of the Slave Trade in an African American population: mitochondrial DNA, Y chromosome and HTLV-1 analysis in the Noir Marron of French Guiana.
October 2010, BMC evolutionary biology,
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
The genetic diversity of three peculiar populations descending from the slave trade: Gm study of Noir Marron from French Guiana.
October 2009, Comptes rendus biologies,
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
Risk factors for HIV-1 infection among pregnant women in French Guiana.
June 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
Suicide risk among prisoners in French Guiana: prevalence and predictive factors.
May 2017, BMC psychiatry,
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
Prevalence and risk factors for micronutrient deficiencies during pregnancy in Cayenne, French Guiana.
January 2021, Food & nutrition research,
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
Risk factors for high blood pressure among HIV patients in French Guiana.
August 2008, Journal of acquired immune deficiency syndromes (1999),
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
High variability of HTLV-I in a remote population of Gabon as compared to that of a similar population of French Guiana.
December 2001, Virus genes,
P Tuppin, and J F Lepère, and G Carles, and A Ureta-Vidal, and Y Gérard, and C Peneau, and P Tortevoye, and G de Thé, and J P Moreau, and A Gessain
Q fever pneumonia in French Guiana: prevalence, risk factors, and prognostic score.
July 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!